Characteristics of Streptococcus pyogenes strains isolated from Chinese children with scarlet fever

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue 12, 2008, Pages 1681-1685

  Liang, Yunmei ^a   Shen, Xuzhuang ^a   Huang, Guoying ^b   Wang, Chuanqing ^b   Shen, Ying ^a   Yang, Yonghong ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Antibiotic resistance; China; Scarlet fever; Streptococcus pyogenes

Indexed keywords

CEFRADINE; CHLORAMPHENICOL; MACROLIDE; OFLOXACIN; PENICILLIN G; SUPERANTIGEN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; CHINESE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCARLET FEVER; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; CEPHRADINE; CHILD; CHILD, PRESCHOOL; CHINA; CHLORAMPHENICOL; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PENICILLINS; PHENOTYPE; POLYMERASE CHAIN REACTION; SCARLET FEVER; STREPTOCOCCUS PYOGENES; SUPERANTIGENS; TETRACYCLINES;

EID: 55649102777     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.00983.x     Document Type: Article

References (31)

1. Chiou CS, Liao TL, Wang TH, Chang HL, Liao JC, Li CC. Epidemiology and molecular characterization of Streptococcus pyogenes. Recovered from scarlet fever patients in central Taiwan from 1996 to 1999. J Clin Microbiol 2004 42 : 3998 4006.
2. Kashiwagi Y. A 23-year longitudinal study on the antibiotic sensitivities of group A streptococci from the scarlet fever patients - 1956-1978. Kansenshogaku Zasshi 1991 65 : 820 32.
3. Grivea IN, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR. Resistance to erythromycin and telithromycin in Streptococcus pyogenes. Isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. J Antimicrob Agents Chemother 2006 50 : 256 61.
4. Yan JJ, Liu CC, Ko WC, Hsu SY, Wu HM, Lin YS, et al. Molecular analysis of group A streptococcal isolates associated with scarlet fever in southern Taiwan between 1993 and 2002. J Clin Microbiol 2003 41 : 4858 61.
5. Green M, Martin JM, Barbadora KA, Beall B, Wald ER. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania. Antimicrob Agents Chemother 2004 48 : 473 6.
6. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989 321 : 1 7.
7. Yamaoka J, Nakamura E, Takeda Y, Imamura S, Minato N. Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C. Infect Immun 1998 66 : 5020 6.
8. Radikas R, Connolly C. Young patients in a young nation: scarlet fever in early nineteenth century rural New England. Pediatr Nurs 2007 33 : 53 5.
9. Briko NI, Filatov NN, Zhuravlev MV, Lytkina IN, Ezhlova EB, Brazhnikov AI, et al. Epidemiological pattern of scarlet fever in recent years. Zh Mikrobiol Epidemiol Immunobiol 2003 5 : 67 72.
10. Dodonov VN, Silich VA, Severov AM, Gladkova KK, Cherkasskaia RS. Patterns in the epidemic process of scarlet fever in various territories differing in respect of climate and geography. Zh Mikrobiol Epidemiol Immunobiol 1975 8 : 15 20.
11. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. 5th ed. Wayne, PA : NCCLS, 2006.
12. Weber P, Filipecki J, Bingen E, Fitoussi F, Goldfarb G, Chauvin JP, et al. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J Antimicrob Chemother 2001 48 : 291 4.
13. Pérez-Trallero E, Montes M, Orden B, Tamayo E, García-Arenzana JM, Marimón JM. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother 2007 51 : 1228 33.
14. Rodríguez-Zurita ME, Solís del Baño S, Robres Guillén P, González Praetorius A, Gimeno Fernández C, Pérez Pomata MT, et al. Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain. Rev Esp Quimioter 2003 16 : 61 4.
15. Mazzariol A, Koncan R, Bahar G, Cornaglia G. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study. J Chemother 2007 19 : 500 7.
16. Mazzariol A, Koncan R, Vitali LA, Cornaglia G. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae. J Antimicrob Chemother 2007 59 : 1171 6.
17. Lloyd CA, Jacob SE, Menon T. Antibiotic resistant beta-hemolytic streptococci. Indian J Pediatr 2007 74 : 1077 80.
18. Creti R, Imperi M, Baldassarri L, Pataracchia M, Recchia S, Alfarone G, et al. emm types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol 2007 45 : 2249 56.
19. Szczypa K, Sadowy E, Izdebski R, Strakova L, Hryniewicz W. Group A streptococci from invasive-disease episodes in Poland are remarkably divergent at the molecular level. J Clin Microbiol 2006 44 : 3975 9.
20. Alonso R, Mateo E, Ezpeleta G, Cisterna R. Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain. Int J Antimicrob Agents 2007 30 : 183 5.
21. Descheemaeker P, Chapelle S, Lammens C, Hauchecorne M, Wijdooghe M, Vandamme P, et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. J Antimicrob Chemother 2000 45 : 167 73.
22. Katz KC, McGeer AJ, Duncan CL, Ashi-Sulaiman A, Willey BM, Sarabia A, et al. Emergence of Macrolide resistance in throat culture isolates of group A Streptococci in Ontario, Canada, in 2001. J Antimicrob Agents Chemother 2003 47 : 2370 2.
23. Bingen E, Bidet P, Mihaila-Amrouche L, Doit C, Forcet S, Brahimi N, et al. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. J Antimicrob Agents Chemother 2004 48 : 3559 62.
24. Hsueh PR, Shyr JM, Wu JJ. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan. Clin Microbiol Infect 2006 12 : 296 8.
25. Zhang WS, Shen XZ, Bergman U, Wang Y, Chen Y, Huang H, et al. Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children's hospitals. Eur J Clin Pharm 2008 in press.
26. Carriço JA, Silva-Costa C, Melo-Cristino J, Pinto FR, de Lencastre H, Almeida JS, et al. Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes. J Clin Microbiol 2006 44 : 2524 32.
27. Luca-Harari B, Ekelund K, Van Der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A. Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Micobiol 2008 46 : 79 86.
28. Krucsó B, Gacs M, Libisch B, Hunyadi ZV, Molnár K, Füzi M, et al. Molecular characterisation of invasive Streptococcus pyogenes isolates from Hungary obtained in 2004 and 2005. Eur J Clin Microbiol Infect Dis 2007 26 : 807 11.
29. Jing HB, Ning BA, Hao HJ, Zheng YL, Chang D, Jiang W, et al. Epidemiological analysis of group A streptococci recovered from patients in China. J Med Microbiol 2006 55 : 1101 7.
30. Yu CE, Ferretti JJ. Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. J Infect Immun 1989 57 : 3715 9.
31. Dmitrieva NF, Trofimov DI, Eshchina AS, Riapis LA, Pavlova OG, Petrova TV, et al. Frequency of genes speA, speB, and speC in Streptococcus pyogenes strains and the identification of the infective agent by polymerase chain reaction. J Zh Mikrobiol Epidemiol Immunobiol 2002 5 : 3 6.